TNFA NASDAQ

TNF Pharmaceuticals, Inc. - Common Stock

Healthcare · Pharmaceuticals
$3.00
+0.21 (+7.5%)
2
Quality Score
fail
Mkt Cap
$1.3M
ROE
-127.7%
Margin
-501.5%
D/E
0.00
Beta
2.11
52W
$0–$2

Wall Street Consensus

7 analysts · Dec 2021
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31 2025-09-02
ROE (TTM) -97.1% -179.1% -233.9% -220.4% -127.7% -127.7%
P/E (TTM) — — — — — —
Net Margin — — — — — -501.5%
Gross Margin — — — — — 24.7%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.62 2.48 1.72 1.40 1.37 1.37

Key Ratios

ROA (TTM)
-64.8%
P/S (TTM)
1.61
P/B
0.2
EPS (TTM)
$-5.93
52W High
$1.95
52W Low
$0.04
$0.04 52-Week Range $1.95

How does TNFA compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

TNFA AARD ACB ACRS ADIL

TNFA valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1.6
▼ 67% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.2
▼ 90% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

TNFA profitability vs Pharmaceuticals peers

ROE
-127.7%
▼ 135% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-501.5%
▼ 959% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
24.7%
▼ 64% below peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-64.8%
▼ 73% below peers (-37.4%)
vs Peers
vs Industry
Weak

TNFA financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
1.4
▼ 59% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
2.1
▲ 124% above peers (0.9)
vs Peers
vs Industry
More volatile

TNFA fundamentals radar

TNFA Peer median Industry

TNFA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TNFA vs peers: key metrics

Latest News

No related news yet